Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Zambon

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Arquivos De Neuro-Psiquiatria|March 30, 2017
Facial and bulbar muscle atrophy in acetylcholine receptor antibody-positive myasthenia gravisRonnyson Susano Grativvol, André Macedo Serafim da Silva, Bruno Fukelmann Guedes, et al.
Atherosclerosis|July 12, 2005
Common hepatic lipase gene promoter variant predicts the degree of neointima formation after carotid endarterectomy: impact of plaque composition and lipoprotein phenotypeAlberto Zambon, Massimo Puato, Elisabetta Faggin, et al.
Seizure|May 21, 2023
Interstitial 6q deletion in a patient presenting with drug-resistant epilepsy and Prader-Willi like phenotype: An electroclinical description with literature reviewGianni Cutillo, Raffaello Bonacchi, Giordano Cecchetti, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 5, 2015
GABAA receptor and LGI1 antibody encephalitis in a patient with thymomaMateus Mistieri Simabukuro, Mar Petit-Pedrol, Luiz H Castro, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2025
Contemporary Management of Familial and Multifactorial Chylomicronemia Syndromes in Italy: Insights From the National LIPIGEN RegistryLaura D'Erasmo, Daniele Tramontano, Alessia Di Costanzo, et al.
Atherosclerosis|October 12, 2023
Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlookVikrama Raja, Carlos Aguiar, Nasreen Alsayed, et al.
Neuromuscular Disorders : NMD|September 30, 2018
Clinical variability of early-onset congenital myasthenic syndrome due to biallelic RAPSN mutations in BrazilEduardo de Paula Estephan, Antonio Alberto Zambon, Paulo Eurípedes Marchiori, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 31, 2025
Consensus document on the role of plasma triglycerides in cardiovascular disease from the Italian Society for the Study of Atherosclerosis (SISA)Alberto Zambon, Luigi Gentile, Federica Galimberti, et al.
Frontiers in Neurology|August 25, 2025
Surgical treatment of myasthenia gravis: 10 years of single center experienceJosé De Sá Moraes Neto, Jaqueline Schaparini Fonini, Francisco De Assis Cavalcanti Neto, et al.
Journal of Clinical Lipidology|December 2, 2025
Long-term efficacy and safety of lomitapide in patients with familial chylomicronemia syndrome: Data from an expanded access programAntonina Giammanco, Laura D'Erasmo, Gabriella Iannuzzo, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Arquivos De Neuro-Psiquiatria|March 30, 2017
Facial and bulbar muscle atrophy in acetylcholine receptor antibody-positive myasthenia gravisRonnyson Susano Grativvol, André Macedo Serafim da Silva, Bruno Fukelmann Guedes, et al.
Atherosclerosis|July 12, 2005
Common hepatic lipase gene promoter variant predicts the degree of neointima formation after carotid endarterectomy: impact of plaque composition and lipoprotein phenotypeAlberto Zambon, Massimo Puato, Elisabetta Faggin, et al.
Seizure|May 21, 2023
Interstitial 6q deletion in a patient presenting with drug-resistant epilepsy and Prader-Willi like phenotype: An electroclinical description with literature reviewGianni Cutillo, Raffaello Bonacchi, Giordano Cecchetti, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 5, 2015
GABAA receptor and LGI1 antibody encephalitis in a patient with thymomaMateus Mistieri Simabukuro, Mar Petit-Pedrol, Luiz H Castro, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2025
Contemporary Management of Familial and Multifactorial Chylomicronemia Syndromes in Italy: Insights From the National LIPIGEN RegistryLaura D'Erasmo, Daniele Tramontano, Alessia Di Costanzo, et al.
Atherosclerosis|October 12, 2023
Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlookVikrama Raja, Carlos Aguiar, Nasreen Alsayed, et al.
Neuromuscular Disorders : NMD|September 30, 2018
Clinical variability of early-onset congenital myasthenic syndrome due to biallelic RAPSN mutations in BrazilEduardo de Paula Estephan, Antonio Alberto Zambon, Paulo Eurípedes Marchiori, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 31, 2025
Consensus document on the role of plasma triglycerides in cardiovascular disease from the Italian Society for the Study of Atherosclerosis (SISA)Alberto Zambon, Luigi Gentile, Federica Galimberti, et al.
Frontiers in Neurology|August 25, 2025
Surgical treatment of myasthenia gravis: 10 years of single center experienceJosé De Sá Moraes Neto, Jaqueline Schaparini Fonini, Francisco De Assis Cavalcanti Neto, et al.
Journal of Clinical Lipidology|December 2, 2025
Long-term efficacy and safety of lomitapide in patients with familial chylomicronemia syndrome: Data from an expanded access programAntonina Giammanco, Laura D'Erasmo, Gabriella Iannuzzo, et al.
Pageof 10